You are here

  • Home
  • Archive
  • Volume 1, Issue 2
  • Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial

Article metrics

Article menu
XML
Gastroenterology and hepatology
Research
Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial

 

Online download statistics by month:

Online download statistics by month: January 2018 to April 2024

AbstractFullPdf
Jan 201813312715
Feb 201813111515
Mar 201816215312
Apr 201812411013
May 20181221109
Jun 201814014013
Jul 201811411411
Aug 20181641668
Sep 201816916512
Oct 201816116117
Nov 201815515519
Dec 201816516511
Jan 201917416819
Feb 201914814814
Mar 201915615523
Apr 201919019015
May 201920920720
Jun 201926626021
Jul 201931931517
Aug 201931431219
Oct 201934434413
Nov 201941040827
Dec 201949949430
Jan 202050650537
Feb 202056955328
Mar 20201246124241
May 202034534131
Jun 202030629945
Jul 202037036915
Aug 202035735428
Sep 202027727719
Oct 202037637520
Nov 202048548030
Dec 202058757331
Jan 202168367951
Feb 202140339827
Mar 202164563641
Apr 202143243115
May 202131030719
Jun 202134635821
Jul 202144445542
Aug 202151753338
Sep 202134235636
Oct 202136137133
Nov 2021403832
Dec 202128829320
Jan 202235836621
Feb 202228729728
Mar 202231232229
Apr 202218919737
May 202218518037
Jun 202219718915
Jul 202223623710
Aug 20222112119
Sep 202230430612
Oct 202223423515
Nov 20222902899
Dec 20221781782
Jan 20232422418
Feb 20232542535
Mar 20232622526
Apr 20232422267
May 202318117415
Jun 20232392272
Jul 202320520411
Aug 202317116610
Sep 20232082093
Oct 20231761756
Nov 20231771797
Dec 20231091092
Jan 202437364
Feb 202478762
Mar 202468667
Apr 2024767513
Total20710205801405